Cardiovascular care is transitioning from primarily managing acute conditions to focusing on prevention and interventions for ...
Two 'breakthrough' medicines have no worthwhile benefits, scientists say - so where do hopes really lie?
Bayer AG expects its pharmaceutical business to return to mid‑single‑digit growth from 2027 and aims to expand its operating ...
Every 67 seconds, someone in the United States develops Alzheimer’s disease. By April 2026, roughly 7 million Americans aged ...
Momentous - that's how one leading UK dementia charity described the approval of the Alzheimer's drug lecanemab back in ...
Kumamoto University researchers discover that combining two advanced heart imaging techniques can predict life-threatening ...
The study shows that disease severity and poor prognosis in ATTR-CM are associated with elevated levels of mid-regional ...
Royal Philips has received FDA 510(k) clearance for its Spectral CT Verida system, bringing the company’s AI-powered spectral CT technology to the U.S. The system combines always-on spectral imaging ...
Guam Memorial Hospital Authority started using additional advanced medical technologies that enhance diagnostic imaging and heart care. These additions include intravascular ultrasound, IVUS, ...
Drugs that target amyloid beta proteins in the brain likely have no clinically meaningful positive effects, while increasing ...
Two studies presented at the American College of Cardiology Scientific Session offered insights into how to diagnose and ...
What if doctors could determine heart health before ever stepping into the operating room? At Kennesaw State University, ...